Jennifer Bath is the founder of IPA (ImmunoPrecise Antibodies). IPA (ImmunoPrecise Antibodies) has raised $200M in total funding.
Dr. Jennifer Bath is the CEO and President of ImmunoPrecise Antibodies (IPA), a global leader in therapeutic antibody discovery and development. She has raised more than $200 million in capital and managed acquisitions across her career. Bath is also a co-founder of IPA and serves on its board of directors.
Full founder directory · Investor directory · Company funding database · Fundraising library